Feasibility study of immediate breast reconstruction with fusion fascia combined with implants.
10.3760/cma.j.cn112152-20220419-00270
- Author:
Zu Jin CHEN
1
;
Ao Xiang CHEN
1
;
Bin ZHANG
1
;
Xin WANG
1
;
Xu Chen CAO
1
Author Information
1. Department of Breast Surgery, National Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Breast reconstruction;
Fused fascia;
Prosthesis
- MeSH:
Humans;
Animals;
Cattle;
Female;
Mastectomy/methods*;
Retrospective Studies;
Breast Implants/adverse effects*;
Feasibility Studies;
Mammaplasty/methods*;
Breast Neoplasms/complications*;
Treatment Outcome;
Postoperative Complications/surgery*
- From:
Chinese Journal of Oncology
2023;45(6):514-518
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the oncologic and surgical safety of the fused fascia method for immediate breast reconstruction with implants. Methods: The clinical data of 343 patients with immediate breast reconstruction with implants in Tianjin Medical University Cancer Hospital from 2014-2017 were retrospectively analyzed to compare the 5-year local recurrence-free survival, 5-year disease-free survival and 5-year overall survival of patients with breast reconstruction by fusion fascia and other methods, and to analyze the complication incidences of implant removal between different implant groups. Results: Of the 343 patients with breast reconstruction, 95 were in the fused fascia group (fascia group) and 248 were in the non-fascia group (25 in the bovine pericardial patch group and 223 in the muscle flap group). At a median follow-up of 49 months, the differences in 5-year local recurrence-free survival (90.1% and 94.9%, respectively), 5-year disease-free survival (89.2% and 87.6%, respectively), and 5-year overall survival (95.2% and 95.1%, respectively) between patients in the fascial and non-fascial groups were not statistically significant (P>0.05). The complication incidence of implant removal was 24.0% (6/25) in the patch group and 2.1% (2/95) and 2.2% (5/223) in the fascia and muscle flap groups, respectively. Conclusion: Immediate breast reconstruction with fused fascial combined with implant is safe and feasible, less invasive than muscle flaps, more economical and with fewer complications than patches.
